With effective therapies available, the findings suggest screening with nuclear imaging should be more frequent in this ...

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the ...

The RISE @ ESC Congress 2025 meeting made clear that policies matter, but so too do interpersonal connections on a local ...

CMS is proposing a 57% reduction in payment, an amount that could cripple the burgeoning interest in caring for ATTR-CM.

Where the inflammatory hypothesis started, and where it's going—Paul Ridker shares his thoughts.

MADRID, Spain—Stopping oral anticoagulation (OAC) improves outcomes among patients who remain free from atrial arrhythmia ...

Increases in procedural speed and safety, however, support the continuing shift to the newer modality, one expert says.

This highlights the need to prospectively study these types of tools before implementing them in routine care, researchers ...

Vinod Thourani and Matthew Price review the 2-year outcomes of the TRILUMINATE trial and discuss clinical progression among ...

The post-hoc analysis can’t tease out what’s driving the long-term advantage, though some experts have possible explanations.

In addition to less restrictive guidance for some high-risk patients, the document advises vaginal birth whenever possible.

The World Heart Federation (WHF) is once again pushing the adoption of single pill combination (SPC) drugs, also referred to ...